206 related articles for article (PubMed ID: 36380569)
1. Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation.
Hijazi Z; Benz AP; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Granger CB; Kastner P; Lopes RD; Ziegler A; Oldgren J; Siegbahn A; Wallentin L
Eur Heart J; 2023 Jan; 44(3):208-218. PubMed ID: 36380569
[TBL] [Abstract][Full Text] [Related]
2. Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.
Gkarmiris KI; Lindbäck J; Alexander JH; Granger CB; Kastner P; Lopes RD; Ziegler A; Oldgren J; Siegbahn A; Wallentin L; Hijazi Z
J Am Heart Assoc; 2024 Apr; 13(7):e033720. PubMed ID: 38529655
[TBL] [Abstract][Full Text] [Related]
3. Bone Morphogenetic Protein 10-A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation.
Hennings E; Blum S; Aeschbacher S; Coslovsky M; Knecht S; Eken C; Lischer M; Paladini RE; Krisai P; Reichlin T; Rodondi N; Beer JH; Ammann P; Conte G; De Perna ML; Kobza R; Blum MR; Bossard M; Kastner P; Ziegler A; Müller C; Bonati LH; Pfister O; Zuern CS; Conen D; Kühne M; Osswald S;
J Am Heart Assoc; 2023 Mar; 12(6):e028255. PubMed ID: 36926939
[TBL] [Abstract][Full Text] [Related]
4. Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy.
RAF and RENO-EXTEND Investigators*
Eur Stroke J; 2023 Sep; 8(3):722-730. PubMed ID: 37458099
[TBL] [Abstract][Full Text] [Related]
5. Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation.
Benz AP; Hijazi Z; Lindbäck J; Connolly SJ; Eikelboom JW; Kastner P; Ziegler A; Alexander JH; Granger CB; Lopes RD; Oldgren J; Siegbahn A; Wallentin L
Europace; 2023 Jul; 25(7):. PubMed ID: 37461214
[TBL] [Abstract][Full Text] [Related]
6. Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study.
Anjum M; Ariansen I; Hjellvik V; Selmer R; Kjerpeseth LJ; Skovlund E; Myrstad M; Ellekjær H; Christophersen IE; Tveit A; Berge T
Eur Heart J; 2024 Jan; 45(1):57-66. PubMed ID: 37995254
[TBL] [Abstract][Full Text] [Related]
7. Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation.
Staszewsky L; Meessen JMTA; Novelli D; Wienhues-Thelen UH; Disertori M; Maggioni AP; Masson S; Tognoni G; Franzosi MG; Lucci D; Latini R
BMC Cardiovasc Disord; 2021 Nov; 21(1):553. PubMed ID: 34798808
[TBL] [Abstract][Full Text] [Related]
8. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
10. Disturbed atrial metabolism, shear stress, and cardiac load contribute to atrial fibrillation after ablation: AXAFA biomolecule study.
Chua W; Khashaba A; Canagarajah H; Nielsen JC; di Biase L; Haeusler KG; Hindricks G; Mont L; Piccini J; Schnabel RB; Schotten U; Wienhues-Thelen UH; Zeller T; Fabritz L; Kirchhof P
Europace; 2024 Feb; 26(2):. PubMed ID: 38266130
[TBL] [Abstract][Full Text] [Related]
11. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
[TBL] [Abstract][Full Text] [Related]
12. The association between increasing oral anticoagulant prescribing and atrial fibrillation related stroke in Ireland.
Kennedy C; Gabr A; McCormack J; Collins R; Barry M; Harbison J
Br J Clin Pharmacol; 2022 Jan; 88(1):178-186. PubMed ID: 34131941
[TBL] [Abstract][Full Text] [Related]
13. Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study.
Wilson D; Ambler G; Banerjee G; Shakeshaft C; Cohen H; Yousry TA; Al-Shahi Salman R; Lip GYH; Houlden H; Brown MM; Muir KW; Jäger HR; Werring DJ;
J Neurol Neurosurg Psychiatry; 2019 Mar; 90(3):320-325. PubMed ID: 30455404
[TBL] [Abstract][Full Text] [Related]
14. Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.
Hijazi Z; Wallentin L; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Granger CB; Lopes RD; Pol T; Yusuf S; Oldgren J; Siegbahn A
J Am Heart Assoc; 2020 Dec; 9(24):e018984. PubMed ID: 33292046
[TBL] [Abstract][Full Text] [Related]
15. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience.
Galloo X; Carmeliet T; Prihadi EA; Lochy S; Scott B; Verheye S; Schoors D; Vermeersch P
Acta Clin Belg; 2022 Apr; 77(2):255-260. PubMed ID: 32951514
[TBL] [Abstract][Full Text] [Related]
16. Association of bone morphogenetic protein 10 and recurrent atrial fibrillation after catheter ablation.
Hennings E; Aeschbacher S; Coslovsky M; Paladini RE; Meyre PB; Voellmin G; Blum L; Kastner P; Ziegler A; Conen D; Zuern CS; Krisai P; Badertscher P; Sticherling C; Osswald S; Knecht S; Kühne M
Europace; 2023 Jun; 25(6):. PubMed ID: 37314197
[TBL] [Abstract][Full Text] [Related]
17. Use of oral anticoagulants after ischaemic stroke in patients with atrial fibrillation and cancer.
Atterman A; Asplund K; Friberg L; Engdahl J
J Intern Med; 2020 Oct; 288(4):457-468. PubMed ID: 32386073
[TBL] [Abstract][Full Text] [Related]
18. Insertable cardiac monitoring results in higher rates of atrial fibrillation diagnosis and oral anticoagulation prescription after ischaemic stroke.
Boriani G; Auricchio A; Botto GL; Joseph JM; Roberts GJ; Grammatico A; Nabutovsky Y; Piccini JP
Europace; 2023 Aug; 25(9):. PubMed ID: 37490349
[TBL] [Abstract][Full Text] [Related]
19. Ischaemic stroke and bleeding rates in 'real-world' atrial fibrillation patients.
Ogilvie IM; Welner SA; Cowell W; Lip GY
Thromb Haemost; 2011 Jul; 106(1):34-44. PubMed ID: 21614409
[TBL] [Abstract][Full Text] [Related]
20. Oral anticoagulants and outcomes in adults ≥80 years with atrial fibrillation: A global federated health network analysis.
Harrison SL; Buckley BJR; Ritchie LA; Proietti R; Underhill P; Lane DA; Lip GYH
J Am Geriatr Soc; 2022 Aug; 70(8):2386-2392. PubMed ID: 35587227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
